Cited by 1,011Inflammatory mediators and NSAID effectsReceptor Mechanisms and SignalingEicosanoids and Hypertension Pharmacology

The DOI matches its Crossref record; 154 of the 154 references it cites were found in a registry or an index.

Prostanoid Receptors: Subtypes and Signaling

Breyer, Richard M, Bagdassarian, Carey K, Myers, Scott A, Breyer, Matthew D·2001·Annual Review of Pharmacology and Toxicology

DOI 10.1146/annurev.pharmtox.41.1.661

Open this paper in CoChat — free account

Abstract

Cyclooxygenases metabolize arachidonate to five primary prostanoids: PGE 2, PGF 2α, PGI 2, TxA 2, and PGD 2. These autacrine lipid mediators interact with specific members of a family of distinct G-protein-coupled prostanoid receptors, designated EP, FP, IP, TP, and DP, respectively. Each of these receptors has been cloned, expressed, and characterized. This family of eight prostanoid receptor complementary DNAs encodes seven transmembrane proteins which are typical of G-protein-coupled receptors and these receptors are distinguished by their ligand-binding profiles and the signal transduction pathways activated on ligand binding. Ligand-binding selectivity of these receptors is determined by both the transmembrane sequences and amino acid residues in the putative extracellular-loop regions. The selectivity of interaction between the receptors and G proteins appears to be mediated at least in part by the C-terminal tail region. Each of the EP 1, EP 3, FP, and TP receptors has alternative splice variants described that alter the coding sequence in the C-terminal intracellular tail region. The C-terminal variants modulate signal transduction, phosphorylation, and desensitization of these receptors, as well as altering agonist-independent constitutive activity.

Integrity signals

Registry

Crossref · 10.1146/annurev.pharmtox.41.1.661

Cites

154 of 154 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation
Moncada, S., Gryglewski, R. J., Bunting, S., & Vane, J. R. (1976) · Nature · doi:10.1038/263663a0 · Cited by 3,593
Prostanoid Receptors: Structures, Properties, and Functions
Narumiya, S., Sugimoto, Y., & Ushikubi, F. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1193 · Cited by 2,417
International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes.
Coleman, R. A., Smith, W. L., & Narumiya, S. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06784-5 · Cited by 1,747
G Protein-coupled Receptors
Ji, T. H., Grossmann, M., & Ji, I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.28.17299 · Cited by 1,281
G-protein-coupled receptor heterodimerization modulates receptor function
Jordan, B. A., & Devi, L. A. (1999) · Nature · doi:10.1038/21441 · Cited by 1,169
The probable arrangement of the helices in G protein‐coupled receptors.
Baldwin, J. M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05814.x · Cited by 968
Prostacyclin Synthase Expression Is Decreased in Lungs from Patients with Severe Pulmonary Hypertension
Tuder, R. M., Cool, C. D., Geraci, M. W., Wang, J., Abman, S. H., Wright, L. A., Badesch, D. B., & Voelkel, N. F. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.6.9804054 · Cited by 804
Altered pain perception and inflammatory response in mice lacking prostacyclin receptor
Murata, T., Ushikubi, F., Matsuoka, T., Hirata, M., Yamasaki, A., Sugimoto, Y., Ichikawa, A., Aze, Y., Tanaka, T., Yoshida, N., et al. (1997) · Nature · doi:10.1038/41780 · Cited by 773
Cloning and expression of cDNA for a human thromboxane A2 receptor
Hirata, M., Hayashi, Y., Ushikubi, F., Yokota, Y., Kageyama, R., Nakanishi, S., & Narumiya, S. (1991) · Nature · doi:10.1038/349617a0 · Cited by 679
Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3
Ushikubi, F., Segi, E., Sugimoto, Y., Murata, T., Matsuoka, T., Kobayashi, T., Hizaki, H., Tuboi, K., Katsuyama, M., Ichikawa, A., et al. (1998) · Nature · doi:10.1038/26233 · Cited by 677

Show all 152 references

Research works printed but not linked: 18

Coleman RA, 1994, Pharmacol. Rev., 46, 205
Leach AR. 1996.Molecular Modelling. Essex, England: Longman Ltd.pp. 25–90
Kolakowski L, 1994, Mol. Pharmacol. Recept. Channels, 2, 1
Morinelli TA, 1989, J. Pharmacol. Exp. Ther., 251, 557
Kinsella BT, 1997, J. Pharmacol. Exp. Ther., 281, 957
Funk CD, 1993, Mol. Pharmacol., 44, 934
Sakamoto K, 1994, J. Biol. Chem., 5, 3381
Fujino H, 2000, Mol. Pharmacol., 57, 353
Coleman RA, Kennedy I, Humphrey PPA, Bunce K, Lumley P. 1990.Prostanoids and their receptors.InComprehensive Medicinal Chemistry, ed. JC Emmet, pp. 643–714. Oxford, UK: Pergamon
Abramovitz M, 1995, Adv. Prostaglandin Thromboxane Leukot. Res., 23, 499
Regan JW, 1994, Mol. Pharmacol., 46, 213
Guan Y, 1996, J. Am. Soc. Nephrol, 7, 1646
Nishigaki N, 1996, Mol. Pharmacol., 50, 1031
Perkins W, 1991, J. Pharmacol. Exp. Ther., 259, 1004
10.1042/0264-6021:3400365 · DOI
Audoly L, 1999, J. Pharmacol. Exp. Ther., 289, 140
Edwards RM, 1985, Am. J. Physiol., 248, F779
Kotani M, 1995, Mol. Pharmacol., 48, 869

Sorted by citations

Items 201–300 of 1,000

Role of bioactive lipid mediators in obese adipose tissue inflammation and endocrine dysfunction
Lopategi, A., López‐Vicario, C., Alcaraz‐Quiles, J., García‐Alonso, V., Rius, B., Titos, E., & Clària, J. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.09.033 · Cited by 81
EP4 as a Therapeutic Target for Aggressive Human Breast Cancer
Majumder, M., Nandi, P., Omar, A., Ugwuagbo, K. C., & Lala, P. K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041019 · Cited by 78
Identification of Novel Endogenous Cytochrome P450 Arachidonate Metabolites with High Affinity for Cannabinoid Receptors
Chen, J., Chen, J., Imig, J. D., Wei, S. D., Hachey, D. L., Guthi, J. S., Falck, J. R., Capdevila, J. H., & Harris, R. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709873200 · Cited by 83
Regulation of breast cancer-associated aromatase promoters
Chen, D., Reierstad, S., Lü, M., Lin, Z., Ishikawa, H., & Bulun, S. E. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.05.038 · Cited by 78
PGE2 Signaling Through the EP4 Receptor on Fibroblasts Upregulates RANKL and Stimulates Osteolysis
Tsutsumi, R., Xie, C. L., Wei, X., Zhang, M., Zhang, X., Flick, L. M., Schwarz, E. M., & O’Keefe, R. J. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090412 · Cited by 78
Induction of Hyaluronic Acid Synthase 2 (HAS2) in Human Vascular Smooth Muscle Cells by Vasodilatory Prostaglandins
Sussmann, M., Sarbia, M., Meyer-Kirchrath, J., Nüsing, R. M., Schrör, K., & Fischer, J. W. (2004) · Circulation Research · doi:10.1161/01.res.0000119169.87429.a0 · Cited by 78
Non-acidic pyrazole EP1 receptor antagonists with in vivo analgesic efficacy
Hall, A., Billinton, A., Brown, S. H., Clayton, N. M., Chowdhury, A., Giblin, G. M. P., Goldsmith, P., Hayhow, T. G., Hurst, D. N., Kilford, I. R., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.04.018 · Cited by 77
Binding of pregnancy-specific glycoprotein 17 to CD9 on macrophages induces secretion of IL-10, IL-6, PGE2, and TGF-β1
Ha, C. T., Waterhouse, R., Wessells, J., Wu, J. A., & Dveksler, G. S. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0804453 · Cited by 77
The role of prostacyclin synthase and thromboxane synthase signaling in the development and progression of cancer
Cathcart, M. C., Reynolds, J. V., O'Byrne, K. J., & Pidgeon, G. P. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.01.006 · Cited by 76
Prostaglandin E2 receptors EP2 and EP4 are up-regulated in peritoneal macrophages and joints of pristane-treated mice and modulate TNF-α and IL-6 production
Akaogi, J., Yamada, H., Kuroda, Y., Nacionales, D. C., Reeves, W. H., & Satoh, M. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.1203627 · Cited by 76
MAP kinases and the inflammatory signaling cascade as targets for the treatment of endometriosis?
Santulli, P., Marcellin, L., Tosti, C., Chouzenoux, S., Cerles, O., Borghese, B., Batteux, F., & Chapron, C. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2015.1090974 · Cited by 75
Polyunsaturated Fatty Acid-Derived Lipid Mediators and T Cell Function
Nicolaou, A., Mauro, C., Urquhart, P., & Marelli‐Berg, F. M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00075 · Cited by 78
Roles of prostaglandins in tumor-associated lymphangiogenesis with special reference to breast cancer
Lala, P. K., Nandi, P., & Majumder, M. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-018-9734-0 · Cited by 75
Role of in Asthma and Nonasthmatic Eosinophilic Bronchitis
Sastre, B., & del Pozo, V. (2012) · Mediators of Inflammation · doi:10.1155/2012/645383 · Cited by 74
TRP-channels as key integrators of lipid pathways in nociceptive neurons
Sisignano, M., Bennett, D., Geißlinger, G., & Scholich, K. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.11.002 · Cited by 76
TNF‐α/IFN‐γ‐induced iNOS expression increased by prostaglandin E2 in rat primary astrocytes via EP2‐evoked cAMP/PKA and intracellular calcium signaling
Hsiao, H., Mak, O., Yang, C., Liu, Y., Fang, K., & Tzeng, S. (2006) · Glia · doi:10.1002/glia.20453 · Cited by 73
Prostaglandin E2 Potentiation of P2X3 Receptor Mediated Currents in Dorsal Root Ganglion Neurons
Wang, C., Li, G.-W., & Huang, L.-Y. M. (2007) · Molecular Pain · doi:10.1186/1744-8069-3-22 · Cited by 73
Pharmacological activation of the prostaglandin E2 receptor EP4 improves cardiac function after myocardial ischaemia/reperfusion injury
Hishikari, K., Suzuki, J., Ogawa, M., Isobe, K., Takahashi, T., Onishi, M., Takayama, K., & Isobe, M. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn254 · Cited by 73
Prostaglandins and Their Receptors in Insect Biology
STANLEY, D. W., & Kim, Y. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00105 · Cited by 73
Aromatase and cyclooxygenases: enzymes in breast cancer
Brueggemeier, R. W., Richards, J. A., & Petrel, T. A. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00380-7 · Cited by 73
Role of Cyclooxygenase 2 in Protein Kinase C βII-mediated Colon Carcinogenesis
Yu, W., Murray, N. R., Weems, C. R., Chen, L., Guo, H., Ethridge, R. T., Ceci, J. D., Evers, B. M., Thompson, E. A., & Fields, A. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211424200 · Cited by 73
Adipose-derived stem cells ameliorate colitis by suppression of inflammasome formation and regulation of M1-macrophage population through prostaglandin E2
Park, H. J., Kim, J., Saima, F. T., Rhee, K., Hwang, S., Kim, M. Y., Baik, S. K., Eom, Y. W., & Kim, H. S. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.03.096 · Cited by 72
Multiple roles of the PGE 2 ‐ EP receptor signal in vascular permeability
Omori, K., Kida, T., Hori, M., Ozaki, H., & Murata, T. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12815 · Cited by 78
Preoperative nonsteroidal anti-inflammatory agents: Review of the literature
Savage, M. G., & Henry, M. A. (2004) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/j.tripleo.2004.01.012 · Cited by 72
Misoprostol, an anti-ulcer agent and PGE2 receptor agonist, protects against cerebral ischemia
Li, J., Liang, X., Wang, Q., BREYER, R. M., McCullough, L. D., & Andreasson, K. I. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.04.054 · Cited by 72
Self-citation
Antagonists of the EP3 Receptor for Prostaglandin E2 Are Novel Antiplatelet Agents That Do Not Prolong Bleeding
Singh, J., Zeller, W. E., Zhou, N., Hategen, G., Mishra, R. K., Polozov, A., Yu, P., Onua, E., Zhang, J., Zembower, D. E., et al. (2009) · ACS Chemical Biology · doi:10.1021/cb8002094 · Cited by 71
Lipid mediators and allergic diseases
Fanning, L. B., & Boyce, J. A. (2013) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2013.06.031 · Cited by 70
Altered hippocampal long‐term synaptic plasticity in mice deficient in the PGE2 EP2 receptor
Yang, H., Zhang, J., BREYER, R. M., & Chen, C. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05766.x · Cited by 70
Self-citation
COX-2 Elevates Oncogenic miR-526b in Breast Cancer by EP4 Activation
Majumder, M., Landman, E., Liu, L., Hess, D. A., & Lala, P. K. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0543 · Cited by 70
Prostanoid signaling: Dual role for prostaglandin E2 in neurotoxicity
Milatović, D., Montine, T. J., & Aschner, M. (2011) · NeuroToxicology · doi:10.1016/j.neuro.2011.02.004 · Cited by 70
Effects of cholesterol depletion on compartmentalized cAMP responses in adult cardiac myocytes
Agarwal, S. R., MacDougall, D. A., Tyser, R. C. V., Pugh, S. D., Calaghan, S. C., & Harvey, R. D. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.11.015 · Cited by 70
PDE4 inhibitors roflumilast and rolipram augment PGE 2 inhibition of TGF-β1-stimulated fibroblasts
Togo, S., Liu, X., Wang, X., Sugiura, H., Kamio, K., Kawasaki, S., Kobayashi, T., Ertl, R. F., Ahn, Y., Holz, O., et al. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00508.2007 · Cited by 70
Prostaglandin F2α stimulates motility and invasion in colorectal tumor cells
Qualtrough, D., Kaidi, A., Chell, S. D., Jabbour, H. N., Williams, A. C., & Paraskeva, C. (2007) · International Journal of Cancer · doi:10.1002/ijc.22755 · Cited by 69
EP2 and EP4 receptors differentially mediate MAPK pathways underlying anabolic actions of prostaglandin E2 on bone formation in rat calvaria cell cultures
Minamizaki, T., Yoshiko, Y., Kozai, K., Aubin, J. E., & Maeda, N. (2009) · Bone · doi:10.1016/j.bone.2009.02.010 · Cited by 69
Prostanoids and their receptors that modulate dendritic cell‐mediated immunity
Gualde, N., & Harizi, H. (2004) · Immunology and Cell Biology · doi:10.1111/j.0818-9641.2004.01251.x · Cited by 69
Clinical Insights for Cervical Ripening and Labor Induction Using Prostaglandins
Pierce, S., Bakker, R., Myers, D. A., & Edwards, R. K. (2018) · American Journal of Perinatology Reports · doi:10.1055/s-0038-1675351 · Cited by 69
Cyclooxygenase enzymes in allergic inflammation and asthma
Carey, M. A., Germolec, D. R., Langenbach, R. I., & Zeldin, D. C. (2003) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(03)00076-0 · Cited by 69
Prostacyclin Induces Apoptosis of Vascular Smooth Muscle Cells by a cAMP-Mediated Inhibition of Extracellular Signal-Regulated Kinase Activity and Can Counteract the Mitogenic Activity of Endothelin-1 or Basic Fibroblast Growth Factor
Li, R.-C., Cindrová‐Davies, T., Skepper, J. N., & Sellers, L. A. (2004) · Circulation Research · doi:10.1161/01.res.0000121568.40692.97 · Cited by 69
The Roles of Various Prostaglandins in Fibrosis: A Review
Li, K., Zhao, J., Wang, M., Niu, L., Wang, Y., Li, Y., & Zheng, Y. (2021) · Biomolecules · doi:10.3390/biom11060789 · Cited by 68
The Prostaglandin E2 Receptor, EP2, Stimulates Keratinocyte Proliferation in Mouse Skin by G Protein-dependent and β-Arrestin1-dependent Signaling Pathways
Chun, K., Lao, H., & Langenbach, R. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.117689 · Cited by 68
The specific thromboxane receptor antagonist S18886: pharmacokinetic and pharmacodynamic studies
Gaussem, P., Reny, J., Thalamas, C., CHATELAIN, N., KROUMOVA, M., JUDE, B., Boneu, B., & Fiessinger, J. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01468.x · Cited by 68
Rationale and Design of a Randomized, Double-Blind, Parallel-Group Study of Terutroban 30 mg/day versus Aspirin 100 mg/day in Stroke Patients: The Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attack (PERFORM) Study
Bousser, M., Amarenco, P., Chamorro, Á., Fisher, M., Ford, I., Fox, K. M., Hennerici, M. G., Mattle, H. P., Rothwell, P. M., & on behalf of the PERFORM Study Investigators (2009) · Cerebrovascular Diseases · doi:10.1159/000212671 · Cited by 68
Involvement of Fatty Acids and Their Metabolites in the Development of Inflammation in Atherosclerosis
Kotlyarov, S. N., & Котлярова, А. А. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031308 · Cited by 67
Principles of Immunopharmacology
Nijkamp, F. P., & Parnham, M. J. (2011) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0346-0136-8 · Cited by 73
Effect of PF-04217329 a prodrug of a selective prostaglandin EP2 agonist on intraocular pressure in preclinical models of glaucoma
Prasanna, G., Carreiro, S. T., Anderson, S., Gukasyan, H. J., Sartnurak, S., Younis, H. S., Gale, D. C., Xiang, C. D., Wells, P. A., Dinh, D. M., et al. (2011) · Experimental Eye Research · doi:10.1016/j.exer.2011.02.015 · Cited by 69
Molecular Pathways and Cellular Metabolism in Colorectal Cancer
Hagland, H. R., Berg, M., Jolma, I. W., Carlsen, A., & Søreide, K. (2013) · Digestive Surgery · doi:10.1159/000347166 · Cited by 67
A phase II trial of calcitriol and naproxen in recurrent prostate cancer.
Srinivas, S., & Feldman, D. (2009) · PubMed · Cited by 66
A Generalizable Platform for Interrogating Target- and Signal-Specific Consequences of Electrophilic Modifications in Redox-Dependent Cell Signaling
Lin, H., Haegele, J. A., Disare, M. T., Lin, Q., & Aye, Y. (2015) · Journal of the American Chemical Society · doi:10.1021/ja5132648 · Cited by 65
Impaired cognition, sensorimotor gating, and hippocampal long-term depression in mice lacking the prostaglandin E2 EP2 receptor
Savonenko, A., Muñoz, P., Melnikova, T., Wang, Q., Liang, X., Breyer, R., Montine, T., Kirkwood, A., & Andreasson, K. I. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.01.016 · Cited by 70
Self-citation
Stimulation of prostanoid IP and EP2 receptors dilates retinal arterioles and increases retinal and choroidal blood flow in rats
Mori, A., Saito, M., Sakamoto, K., Narita, M., Nakahara, T., & Ishii, K. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.05.052 · Cited by 65
Suppression of Adipocyte Differentiation by Aldo-keto Reductase 1B3 Acting as Prostaglandin F2α Synthase
Fujimori, K., Ueno, T., Nagata, N., Kashiwagi, K., Aritake, K., Amano, F., & Urade, Y. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.077164 · Cited by 64
A Binding Site for Nonsteroidal Anti-inflammatory Drugs in Fatty Acid Amide Hydrolase
Bertolacci, L., Romeo, E., Veronesi, M., Magotti, P., Albani, C., Dionisi, M., Lambruschini, C., Scarpelli, R., Cavalli, A., Vivo, M. D., et al. (2012) · Journal of the American Chemical Society · doi:10.1021/ja308733u · Cited by 64
Proneoplastic effects of PGE2mediated by EP4 receptor in colorectal cancer
Doherty, G. A., Byrne, S. M., Molloy, E. S., Malhotra, V., Austin, S. C., Kay, E. W., Murray, F. E., & Fitzgerald, D. J. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-207 · Cited by 69
EP1 Receptor-Mediated Migration of the First Trimester Human Extravillous Trophoblast: The Role of Intracellular Calcium and Calpain
Nicola, C., Timoshenko, A. V., Dixon, S. J., Lala, P. K., & Chakraborty, C. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0413 · Cited by 64
A Selective Prostaglandin E2 Receptor Subtype 2 (EP2) Antagonist Increases the Macrophage-Mediated Clearance of Amyloid-Beta Plaques
Fox, B. M., Beck, H. P., Roveto, P. M., Kayser, F., Cheng, Q., Dou, H., Williamson, T. L., Treanor, J. J. S., Liu, H., Jin, L., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00567 · Cited by 64
Age-Related Changes in Bone Morphology Are Accelerated in Group VIA Phospholipase A2 (iPLA2β)-Null Mice
Ramanadham, S., Yarasheski, K. E., Silva, M. J., Wohltmann, M., Novack, D. V., Christiansen, B., Tu, X., Zhang, S., Lei, X., & TURK, J. W. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070756 · Cited by 64
Nicotine stimulates IL-8 expression via ROS/NF-κB and ROS/MAPK/AP-1 axis in human gastric cancer cells
Lian, S., Li, S., Zhu, J., Xia, Y., & Jung, Y. D. (2021) · Toxicology · doi:10.1016/j.tox.2021.153062 · Cited by 65
COX-2 induces oncogenic micro RNA miR655 in human breast cancer
Majumder, M., Dunn, L., Liu, L., Hasan, A., Vincent, K. M., Brackstone, M., Hess, D. A., & Lala, P. K. (2018) · Scientific Reports · doi:10.1038/s41598-017-18612-3 · Cited by 63
Stereoselective Formation of Carbon−Carbon Bonds via SN2-Displacement: Synthesis of Substituted Cycloalkyl[b]indoles
Hillier, M. C., Marcoux, J.-F., Zhao, D., Grabowski, E. J. J., McKeown, A. E., & Tillyer, R. D. (2005) · The Journal of Organic Chemistry · doi:10.1021/jo051146p · Cited by 63
Sex modifies placental gene expression in response to metabolic and inflammatory stress
Barke, T. L., Money, K. M., Du, L., Serezani, A. P. M., GANNON, M. A., Mirnics, K., & Aronoff, D. M. (2019) · Placenta · doi:10.1016/j.placenta.2019.02.008 · Cited by 62
The evolving complexity of the collecting duct renin–angiotensin system in hypertension
Prieto, M. C., González, A. A., Visniauskas, B., & Navar, L. G. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00414-6 · Cited by 62
Untangling the Web: Toxic and Protective Effects of Neuroinflammation and PGE 2 Signaling in Alzheimer’s Disease
Woodling, N. S., & Andreasson, K. I. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00016 · Cited by 62
A Review of Prostanoid Receptors: Expression, Characterization, Regulation, and Mechanism of Action
Biringer, R. G. (2020) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-020-00585-0 · Cited by 63
A Nonprostanoid EP4 Receptor Selective Prostaglandin E2 Agonist Restores Bone Mass and Strength in Aged, Ovariectomized Rats
Ke, H. Z., Crawford, D. T., Qi, H., Simmons, H. A., Owen, T. A., Paralkar, V. M., Li, M., Lu, B., GRASSER, W. A., Cameron, K. O., et al. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.051110 · Cited by 63
A glance at G-protein-coupled receptors for lipid mediators: a growing receptor family with remarkably diverse ligands
Kostenis, E. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.04.005 · Cited by 61
Prostaglandin E2 Mediates IL-1β-Related Fibroblast Mitogenic Effects in Acute Lung Injury through Differential Utilization of Prostanoid Receptors
White, K. E., Ding, Q., Moore, B. B., Peters-Golden, M. L., Ware, L. B., Matthay, M. A., & Olman, M. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.1.637 · Cited by 61
Lipid mediators of sensitivity in sensory neurons
Park, K. A., & Vasko, M. R. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.09.010 · Cited by 61
Prostaglandin E2 Regulates the Complement Inhibitor CD55/Decay-accelerating Factor in Colorectal Cancer
Holla, V. R., Wang, D., Brown, J. R., Mann, J. R., Katkuri, S., & DuBois, R. N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407403200 · Cited by 61
Prostaglandin E2 alters Wnt-dependent migration and proliferation in neuroectodermal stem cells: implications for autism spectrum disorders
Wong, C. T., Ahmad, E., Li, H., & Crawford, D. A. (2014) · Cell Communication and Signaling · doi:10.1186/1478-811x-12-19 · Cited by 65
Prostanoid receptor gene expression profile in human trabecular meshwork: a quantitative real-time PCR approach.
Kamphuis, W., Schneemann, A., van Beek, L. M., Smit, A.-M., Hoyng, P. F. J., & Koya, E. (2001) · PubMed · Cited by 60
Prostaglandin and myokine involvement in the cyclooxygenase-inhibiting drug enhancement of skeletal muscle adaptations to resistance exercise in older adults
Trappe, T. A., Standley, R. A., Jemioło, B., Carroll, C. C., & Trappe, S. W. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00245.2012 · Cited by 59
A Maladaptive Role for EP4 Receptors in Podocytes
Stitt-Cavanagh, E. M., Faour, W. H., Takami, K., Carter, A., Vanderhyden, B. C., Guan, Y., Schneider, A., Breyer, M. D., & Kennedy, C. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009121234 · Cited by 59
Self-citation
Prostaglandin E2-Dependent Enhancement of Tissue Inhibitors of Metalloproteinases-1 Production Limits Dendritic Cell Migration through Extracellular Matrix
Baratelli, F. E., Heuzé‐Vourc'h, N., Krysan, K., Dohadwala, M., Riedl, K., Sharma, S. P., & Dubinett, S. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5458 · Cited by 59
Increase in PGE2 biosynthesis induces a Bax dependent apoptosis correlated to patients’ survival in glioblastoma multiforme
Lalier-Bretaudeau, L., Cartron, P., Pedelaborde, F., Olivier, C., Loussouarn, D., Martin, S. A., Méflah, K., Ménanteau, J., & Vallette, F. M. (2007) · Oncogene · doi:10.1038/sj.onc.1210303 · Cited by 58
Eicosanoid blood vessel regulation in physiological and pathological states
Imig, J. D. (2020) · Clinical Science · doi:10.1042/cs20191209 · Cited by 63
Role of Oxylipins in the Inflammatory-Related Diseases NAFLD, Obesity, and Type 2 Diabetes
Misheva, M., Johnson, J. S., & McCullagh, J. (2022) · Metabolites · doi:10.3390/metabo12121238 · Cited by 59
Lipopolysaccharide induces inflammation and facilitates lung metastasis in a breast cancer model via the prostaglandin E2-EP2 pathway
LI, S., Xu, X., JIANG, M., Bi, Y., Xu, J., & Han, M. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3258 · Cited by 57
The Role of Cyclooxygenase-2 in Colorectal Carcinogenesis
Liu, Y., Sun, H., Hu, M. S., Zhang, Y., Chen, S., Tighe, S. P., & Zhu, Y. (2016) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2016.09.012 · Cited by 58
PGE 2‐ EP 3 signaling exacerbates hippocampus‐dependent cognitive impairment after laparotomy by reducing expression levels of hippocampal synaptic plasticity‐related proteins in aged mice
Xiao, J., Xiong, B., Zhang, W., Zhou, W., Yang, H., Gao, F., Xiang, H., Manyande, A., Tian, X., & Tian, Y. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12832 · Cited by 57
Neuroprotection by PGE2 receptor EP1 inhibition involves the PTEN/AKT pathway
Zhou, P., Qian, L., Chou, T., & Iadecola, C. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.11.010 · Cited by 57
CCR7-specific migration to CCL19 and CCL21 is induced by PGE2 stimulation in human monocytes: Involvement of EP2/EP4 receptors activation
Côté, S. C., Pasvanis, S., Bounou, S., & Dumais, N. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2008.08.269 · Cited by 57
Prostaglandin E2 Induces Fibroblast Growth Factor 9 via EP3-Dependent Protein Kinase Cδ and Elk-1 Signaling
Chuang, P., Sun, H. S., Chen, T.-M., & Tsai, S. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00941-06 · Cited by 56
Role of mitochondria in programmed cell death mediated by arachidonic acid-derived eicosanoids
Yin, H., Zhou, Y., Zhu, M., Hou, S., Li, Z., Zhong, H., Lu, J., Meng, T., Wang, J., Xia, L., et al. (2012) · Mitochondrion · doi:10.1016/j.mito.2012.10.003 · Cited by 55
Prostaglandin E2 Induces IL-6 and IL-8 Production by the EP Receptors/Akt/NF-κB Pathways in Nasal Polyp-Derived Fibroblasts
Cho, J.-S., Han, I.-H., Lee, H. R., & Lee, H.-M. (2014) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2014.6.5.449 · Cited by 55
PGE2‐mediated upregulation of iNOS in murine breast cancer cells through the activation of EP4 receptors
Timoshenko, A. V., Lala, P. K., & Chakraborty, C. (2003) · International Journal of Cancer · doi:10.1002/ijc.11575 · Cited by 55
Prostacyclin attenuates oxidative damage of myocytes by opening mitochondrial ATP-sensitive K+ channels via the EP3 receptor
Shinmura, K., Tamaki, K., Sato, T., Ishida, H., & Bolli, R. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01003.2004 · Cited by 55
Ligand recognition, unconventional activation, and G protein coupling of the prostaglandin E 2 receptor EP2 subtype
Qu, C., Mao, C., Xiao, P., Shen, Q., Zhong, Y.-N., Yang, F., Shen, D., Tao, X.-N., Zhang, H., Yan, X., et al. (2021) · Science Advances · doi:10.1126/sciadv.abf1268 · Cited by 54
Reduced acute brain injury in PGE2 EP3 receptor-deficient mice after cerebral ischemia
Saleem, S., Kim, Y. T., Maruyama, T., Narumiya, S., & Doré, S. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.01.015 · Cited by 54
Lead Optimization Studies of Cinnamic Amide EP2 Antagonists
Ganesh, T., Jiang, J., Yang, M.-S., & Dingledine, R. J. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5000672 · Cited by 54
Distinct cAMP signaling pathways differentially regulate α2C-adrenoceptor expression: role in serum induction in human arteriolar smooth muscle cells
Chotani, M. A., Mitra, S., Eid, A. H., Han, S. A., & Flavahan, N. A. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01223.2003 · Cited by 54
Expression and biological role of the prostaglandin D synthase/SOX9 pathway in human ovarian cancer cells
Malki, S., Bibeau, F., Notarnicola, C., Roques, S., Berta, P., Poulat, F., & Boizet‐Bonhoure, B. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.04.007 · Cited by 53
Multiple roles of the prostaglandin D2 signaling pathway in reproduction
Rossitto, M., Ujjan, S. A., Poulat, F., & Boizet‐Bonhoure, B. (2014) · Reproduction · doi:10.1530/rep-14-0381 · Cited by 53
Opposing effects of prostaglandin E 2 receptors EP3 and EP4 on mouse and human β-cell survival and proliferation
Carboneau, L., Allan, J. A., Townsend, S. E., Kimple, M. E., BREYER, R. M., & GANNON, M. A. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.04.002 · Cited by 54
Self-citation
Dynamic Regulation, Desensitization, and Cross-talk in Discrete Subcellular Microdomains during β2-Adrenoceptor and Prostanoid Receptor cAMP Signaling
Willoughby, D., Baillie, G. S., Lynch, M. J., Ciruela, A., Houslay, M. D., & Cooper, D. M. F. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706765200 · Cited by 53
Unraveling the Complex Relationship Triad between Lipids, Obesity, and Inflammation
Khan, S. A., Ali, A., Khan, S. A., Zahran, S. A., Damanhouri, G. A., Azhar, E. I., & Qadri, I. (2014) · Mediators of Inflammation · doi:10.1155/2014/502749 · Cited by 55
Prediction of the 3D Structure and Dynamics of Human DP G-Protein Coupled Receptor Bound to an Agonist and an Antagonist
Li, Y., Zhu, F., Vaidehi, N., Goddard, W. A., Sheinerman, F. B., Reiling, S., Morize, I., Mu, L., Harris, K. J., Ardati, A., et al. (2007) · Journal of the American Chemical Society · doi:10.1021/ja070865d · Cited by 52
Newly emerging roles for prostaglandin E2 regulation of hematopoiesis and hematopoietic stem cell engraftment
Durand, E. M., & Zon, L. I. (2010) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32833a888c · Cited by 52
Activation of E-prostanoid 3 receptor in macrophages facilitates cardiac healing after myocardial infarction
Tang, J., Shen, Y., Chen, G., Wan, Q., Wang, K., Zhang, J., Qin, J., Liu, G., Zuo, S., Bo, T., et al. (2017) · Nature Communications · doi:10.1038/ncomms14656 · Cited by 53
siRNA‐mediated knock‐down of COX‐2 in melanocytes suppresses melanogenesis
Kim, J. Y., Shin, J. Y., Kim, M. R., Hann, S., & Oh, S. H. (2012) · Experimental Dermatology · doi:10.1111/j.1600-0625.2012.01483.x · Cited by 52
Dual modulation of synaptic transmission in the nucleus tractus solitarius by prostaglandin E2 synthesized downstream of IL‐1β
Marty, V. N., Hachmane, M. F. E., & Amédée, T. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06296.x · Cited by 56

Authors: Breyer, R. M., Bagdassarian, C. K., Myers, S. A., & Breyer, M. D.
Affiliations: United States Department of Veterans Affairs (US)
ORCID: Breyer, Richard M
Breyer, Matthew D
Venue: Annual Review of Pharmacology and Toxicology
Publisher: Annual Reviews
Published: 2001-04
Volume: 41
Issue: 1
Pages: 661-690
ISSN: 0362-1642 (ISSN-L)
1545-4304
DOI: 10.1146/annurev.pharmtox.41.1.661
OpenAlex: W2129746956
Cited by: 1,011
References: 152
Citations by year: 2026: 7 · 2025: 17 · 2024: 11 · 2023: 22 · 2022: 17 · 2021: 27 · 2020: 37 · 2019: 22 · 2018: 24 · 2017: 32 · 2016: 38 · 2015: 43 · 2014: 50 · 2013: 40 · 2012: 51
FWCI: 5.37
Type: journal article
Language: en
Open access: closed
Locations: The Annual Review of Pharmacology and Toxicology (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute of General Medical Sciences (GM 15431)
National Institute of Diabetes and Digestive and Kidney Diseases (DK37097, DK46205, R01DK037097, R01DK046205)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
Keywords: prostanoid receptors, G protein-coupled receptors, prostaglandins, cyclooxygenase, arachidonic acid metabolism, prostaglandin E2, prostaglandin F2alpha, prostacyclin, thromboxane A2, prostaglandin D2, receptor subtypes, ligand selectivity, splice variants, receptor desensitization, receptor phosphorylation, constitutive receptor activity, signal transduction
MeSH terms: Amino Acid Sequence, Animals, Humans, Molecular Sequence Data, Prostaglandins, Receptors, Prostaglandin, Signal Transduction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Prostanoid Receptors: Subtypes and Signaling

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks